Lagap S.A.

Lagap S.A. is a Swiss pharmaceutical company that operates as a Contract Development and Manufacturing Organisation (CDMO) and offers a range of generics and biosimilars. Founded in 1959, the company specialises in the manufacturing and marketing of branded generic medicines across Europe, the Middle East, Africa, and other emerging markets. Lagap's carefully curated portfolio is designed to address public health needs, providing products with proven safety and efficacy at affordable prices for everyone. The company has successfully maintained a sustainable presence in the international pharmaceutical market by consistently delivering high-quality products.

Services include:
- Contract Development and Manufacturing (CDMO)
- Finished Dosage Forms

Lagap S.A. is dedicated to meeting the evolving needs of the pharmaceutical industry while upholding its commitment to quality and affordability. For more information, visit lagap.ch.